These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32761678)

  • 1. Evaluation of miR-130 family members as circulating biomarkers for the diagnosis of bladder cancer.
    Wang J; Zhao L; Peng X; Liu K; Zhang C; Chen X; Han Y; Lai Y
    J Clin Lab Anal; 2020 Dec; 34(12):e23517. PubMed ID: 32761678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder.
    Singh P; Singh A; Gupta N; Raja KD; Singh P; Agarwal S; Sharma A
    Mol Cell Biochem; 2022 Sep; 477(9):2173-2182. PubMed ID: 35445913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNA panels for specific and early detection in bladder cancer.
    Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T
    Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
    Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
    Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
    Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
    Scheffer AR; Holdenrieder S; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
    World J Urol; 2014 Apr; 32(2):353-8. PubMed ID: 23266581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum miRNAs signature for early diagnosis of bladder cancer.
    Yu Z; Lu C; Lai Y
    Ann Med; 2023 Dec; 55(1):736-745. PubMed ID: 36856518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer diagnosis with a four-miRNA panel in serum.
    Li X; Chen W; Li R; Chen X; Huang G; Lu C; Wen Z; Peng X; Liu K; Zhang C; Li H; Hu Y; Zhao Z; Tao L; Lai Y
    Future Oncol; 2022 Sep; 18(29):3311-3322. PubMed ID: 36047424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Panel of Three Serum MicroRNAs as a Potential Diagnostic Biomarker for Urothelial Carcinoma.
    Li H; Huang G; Lai Y; Ni L; Lai Y
    Oncol Res Treat; 2022; 45(6):344-352. PubMed ID: 35231919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
    BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
    Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
    Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M
    Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p.
    Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W
    Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.
    Chen X
    Medicine (Baltimore); 2019 Jun; 98(26):e16051. PubMed ID: 31261511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.